Dyadic International (NASDAQ:DYAI) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Dyadic International (NASDAQ:DYAI) released its quarterly earnings data on Wednesday. The biotechnology company reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01), Zacks reports. Dyadic International had a negative return on equity of 149.16% and a negative net margin of 188.09%.

Dyadic International Trading Down 3.6 %

NASDAQ:DYAI traded down $0.05 on Wednesday, hitting $1.33. 26,631 shares of the stock were exchanged, compared to its average volume of 68,808. The stock has a fifty day moving average of $1.48 and a 200-day moving average of $1.42. The stock has a market cap of $39.35 million, a PE ratio of -5.78 and a beta of 0.95. The company has a current ratio of 5.15, a quick ratio of 5.15 and a debt-to-equity ratio of 1.54. Dyadic International has a fifty-two week low of $0.93 and a fifty-two week high of $2.67.

Institutional Trading of Dyadic International

A hedge fund recently raised its stake in Dyadic International stock. Bank of America Corp DE raised its holdings in shares of Dyadic International, Inc. (NASDAQ:DYAI) by 16,146.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,132 shares of the biotechnology company’s stock after buying an additional 26,965 shares during the period. Bank of America Corp DE owned about 0.09% of Dyadic International worth $47,000 at the end of the most recent reporting period. 27.95% of the stock is currently owned by institutional investors and hedge funds.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.